Literature DB >> 11112669

Travel-associated Burkholderia pseudomallei infection (Melioidosis) in a patient with cystic fibrosis: a case report.

P Visca1, G Cazzola, A Petrucca, C Braggion.   

Abstract

In September 1997, a 25-year-old Italian woman with cystic fibrosis (CF) spent 3 weeks in Thailand. In August 1998, her pulmonary function rapidly declined, with productive cough and intermittent fever. Chest x-ray films revealed diffuse, small, patchy opacities in the upper lobes. Burkholderia pseudomallei (BP) was isolated from specimens of the patient's sputum and was identified by means of 16S rDNA sequencing. The diagnosis of melioidosis was serologically confirmed. Continuous therapy with ceftazidime and co-trimoxazole and maintenance with co-trimoxazole, doxycycline, and chloramphenicol resulted in eradication of BP. We present the issue of whether patients with CF represent a population particularly at risk for melioidosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11112669     DOI: 10.1086/317528

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  15 in total

Review 1.  Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa, MRSA and Pandoraea spp.

Authors:  Andrew M Jones; A Kevin Webb
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

Review 2.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 3.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 4.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

Review 5.  Mechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis.

Authors:  Herbert P Schweizer
Journal:  Future Microbiol       Date:  2012-12       Impact factor: 3.165

6.  The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study.

Authors:  Bart J Currie; Linda Ward; Allen C Cheng
Journal:  PLoS Negl Trop Dis       Date:  2010-11-30

7.  Morphological Alteration and Survival of Burkholderia pseudomallei in Soil Microcosms.

Authors:  Watcharaporn Kamjumphol; Pisit Chareonsudjai; Suwimol Taweechaisupapong; Sorujsiri Chareonsudjai
Journal:  Am J Trop Med Hyg       Date:  2015-08-31       Impact factor: 2.345

8.  Assessment of fluorescent in situ hybridization and PCR-based methods for rapid identification of Burkholderia cepacia complex organisms directly from sputum samples.

Authors:  A R Brown; J R W Govan
Journal:  J Clin Microbiol       Date:  2007-04-25       Impact factor: 5.948

9.  Cystic fibrosis patient with Burkholderia pseudomallei infection acquired in Brazil.

Authors:  Afonso Luís Barth; Fernando Antonio de Abreu E Silva; Anneliese Hoffmann; Maria Izolete Vieira; Alexandre Prehn Zavascki; Alex Guerra Ferreira; Luiz Gonzaga da Cunha; Rodolpho Mattos Albano; Elizabeth de Andrade Marques
Journal:  J Clin Microbiol       Date:  2007-10-17       Impact factor: 5.948

10.  Burkholderia pseudomallei infection in a cystic fibrosis patient from the Caribbean: a case report.

Authors:  Dimas Mateos Corral; Allan L Coates; Yvonne C W Yau; Raymond Tellier; Mindy Glass; Steven M Jones; Valerie J Waters
Journal:  Can Respir J       Date:  2008 Jul-Aug       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.